ArisGlobal Unveils XDI NavaX Data Intelligence and New AI Agents to Revolutionize Life Sciences
ArisGlobal, a prominent player in the field of AI technology focused on Life Sciences, has recently launched five groundbreaking product initiatives that promise to elevate the operational capabilities of companies in this sector. The announcements were made during "Breakthrough 2026," their annual industry event held in Madrid, Spain. Among the highlights is the introduction of the XDI platform, a next-generation data intelligence cortex designed to facilitate a more integrated approach to decision-making across various departments within pharmaceutical research and development.
The XDI platform is set to redefine how data is utilized by harnessing information from multiple functions and systems. Unlike traditional tools that accelerate individual workflow steps, XDI establishes a rigorous framework that merges meaning, context, and intent, ensuring that decisions related to safety, regulation, clinical practices, and quality are grounded in a shared understanding and cohesive governance. This approach not only mitigates risks but also fosters trust in AI implementations, helping organizations bridge the gap between operational silos.
In addition to XDI, ArisGlobal has expanded its NavaX Agents Suite with three powerful new agents that are aimed at enhancing regulatory information processes. The newly introduced Intelligence Agents automatically interpret regulatory guidelines, transforming them into detailed checklists while evaluating submission files from LifeSphere with a clear compliance rating and justification. The Distribution Agents ensure continuous compliance by automatically addressing changes in regulations, validating them against internal distribution logic, and triggering alert workflows in case of discrepancies. Lastly, the Signals Agents act as intelligent assistants by interpreting user intents and dynamically managing workflows to yield enhanced operational efficiency.
ArisGlobal has also integrated certified translation capabilities via a strategic partnership with TransPerfect Life Sciences into its case data collection workflows. This feature utilizes advanced speech recognition to expedite the translation of non-English safety forms by employing pharmaceutical-specific language models and experienced linguists. The seamless API integration returns translated documents directly into LifeSphere, effectively removing the manual touch from the translation process and significantly accelerating global pharmacovigilance efforts. With the combined capabilities of NavaX and TransPerfect, the time required for translation management has drastically reduced—from around five hours per case to under a minute, delivering unmatched speed, automation, and accuracy in the market.
According to Aman Wasan, CEO of ArisGlobal, the true challenge for the life sciences sector lies not just in adopting AI technologies but operationalizing them at scale with consistency, governance, and measurable business outcomes. This latest suite of product enhancements is aimed at bridging the gap from experimentation to practical application, establishing AI as a dependable foundation for enterprise-level decision-making. Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal, added that these innovations signify a transformative moment in the support technology offers to life science teams, moving from mere automation to the orchestration of intelligence across entire operational ecosystems.
The Breakthrough 2026 event brought together leaders and experts to discuss the crucial theme of AI operationalization, demonstrating how proven use cases are being incorporated into day-to-day practices within the life sciences. As the sector continues to evolve, ArisGlobal remains committed to leading the charge, providing solutions that not only enhance operational efficiency but also align with the broader goals of safety, compliance, and innovation in life science.
XDI: A Game-Changer in Data Intelligence
The XDI platform is set to redefine how data is utilized by harnessing information from multiple functions and systems. Unlike traditional tools that accelerate individual workflow steps, XDI establishes a rigorous framework that merges meaning, context, and intent, ensuring that decisions related to safety, regulation, clinical practices, and quality are grounded in a shared understanding and cohesive governance. This approach not only mitigates risks but also fosters trust in AI implementations, helping organizations bridge the gap between operational silos.
New AI Agents in the Mix
In addition to XDI, ArisGlobal has expanded its NavaX Agents Suite with three powerful new agents that are aimed at enhancing regulatory information processes. The newly introduced Intelligence Agents automatically interpret regulatory guidelines, transforming them into detailed checklists while evaluating submission files from LifeSphere with a clear compliance rating and justification. The Distribution Agents ensure continuous compliance by automatically addressing changes in regulations, validating them against internal distribution logic, and triggering alert workflows in case of discrepancies. Lastly, the Signals Agents act as intelligent assistants by interpreting user intents and dynamically managing workflows to yield enhanced operational efficiency.
NavaX Translation: Streamlining Global Workflows
ArisGlobal has also integrated certified translation capabilities via a strategic partnership with TransPerfect Life Sciences into its case data collection workflows. This feature utilizes advanced speech recognition to expedite the translation of non-English safety forms by employing pharmaceutical-specific language models and experienced linguists. The seamless API integration returns translated documents directly into LifeSphere, effectively removing the manual touch from the translation process and significantly accelerating global pharmacovigilance efforts. With the combined capabilities of NavaX and TransPerfect, the time required for translation management has drastically reduced—from around five hours per case to under a minute, delivering unmatched speed, automation, and accuracy in the market.
Driving Real Change in Life Sciences
According to Aman Wasan, CEO of ArisGlobal, the true challenge for the life sciences sector lies not just in adopting AI technologies but operationalizing them at scale with consistency, governance, and measurable business outcomes. This latest suite of product enhancements is aimed at bridging the gap from experimentation to practical application, establishing AI as a dependable foundation for enterprise-level decision-making. Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal, added that these innovations signify a transformative moment in the support technology offers to life science teams, moving from mere automation to the orchestration of intelligence across entire operational ecosystems.
The Breakthrough 2026 event brought together leaders and experts to discuss the crucial theme of AI operationalization, demonstrating how proven use cases are being incorporated into day-to-day practices within the life sciences. As the sector continues to evolve, ArisGlobal remains committed to leading the charge, providing solutions that not only enhance operational efficiency but also align with the broader goals of safety, compliance, and innovation in life science.
Topics Consumer Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.